Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Appointment Of Mr Janardan Savala As On 26-08-2026 Additional Director In The Capacity Of Executive DirectorBSE filing · raw filing ↗
Q4 FY26 results filed — revenue ₹-0 Cr (−100.3% YoY), PAT ₹-4 Cr (−NaN% YoY)NSE filing · raw filing ↗
Ex-date 16 Sep 2022
⚑ Corp action
Dividend — ₹0.25 per shareNSE filing
Ex-date 15 Sep 2021
⚑ Corp action
Dividend — ₹0.25 per shareNSE filing
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
